Pipenzolate bromide

Pipenzolate bromide
Clinical data
ATC code	A03AB14 (WHO) ;
Identifiers
	IUPAC name 1-Ethyl-3-[2-hydroxy(diphenyl)acetoxy]-1-methylpiperidinium bromide;
JSmol)	Interactive image;
	SMILES CC[N+]1(CCCC(C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C.[Br-];
	InChI InChI=1S/C22H28NO3.BrH/c1-3-23(2)16-10-15-20(17-23)26-21(24)22(25,18-11-6-4-7-12-18)19-13-8-5-9-14-19;/h4-9,11-14,20,25H,3,10,15-17H2,1-2H3;1H/q+1;/p-1 ; Key:XEDCWWFPZMHXCM-UHFFFAOYSA-M ;
	(what is this?) (verify)

Pipenzolate bromide is a pharmaceutical drug that has been studied as an

peptic ulcer.^[1]

Mechanism of action

Pipenzolate bromide acts as an

antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.^[1]

^ ^a ^b "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.